Brief: Breckenridge Pharmaceutical Launches Pomalidomide Capsules
02/03/2026 19:13
March 3 (Reuters) - Breckenridge Pharmaceutical: BRECKENRIDGE PHARMACEUTICAL- BRECKENRIDGE LAUNCHES POMALIDOMIDE CAPSULES BRECKENRIDGE PHARMACEUTICAL-POMALIDOMIDE CAPSULES AVAILABLE ONLY THROUGH PS-POMALIDOMIDE REMS PROGRAM Source text: ID:nPn4Q6sTZa ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees